These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1156 related items for PubMed ID: 18585941

  • 1. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I, Piñol-Ripoll G, Khurana DS, Hardison HH, Kothare SV, Melvin JJ, Marks HG, Legido A.
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [Abstract] [Full Text] [Related]

  • 2. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA.
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
    Gericke CA, Picard F, de Saint-Martin A, Strumia S, Marescaux C, Hirsch E.
    Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
    [Abstract] [Full Text] [Related]

  • 4. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Moeller JJ, Rahey SR, Sadler RM.
    Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
    [Abstract] [Full Text] [Related]

  • 5. The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults.
    Steinhoff BJ, Ueberall MA, Siemes H, Kurlemann G, Schmitz B, Bergmann L, LAM-SAFE Study Group.
    Seizure; 2005 Dec; 14(8):597-605. PubMed ID: 16278088
    [Abstract] [Full Text] [Related]

  • 6. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
    McDonald DG, Najam Y, Keegan MB, Whooley M, Madden D, McMenamin JB.
    Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
    [Abstract] [Full Text] [Related]

  • 7. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
    Evans BK, Kustra RP, Hammer AE.
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy.
    Kothare SV, Kaleyias J, Mostofi N, Valencia I, Melvin JJ, Hobdell E, Khurana DS, Legido A.
    Pediatr Neurol; 2006 May; 34(5):351-4. PubMed ID: 16647993
    [Abstract] [Full Text] [Related]

  • 9. Lamotrigine in children with refractory epilepsy.
    Celebi A, Yalnmzoğlu D, Turanli G, Topaloğlu H, Aysun S, Topçu M.
    Turk J Pediatr; 2008 May; 50(5):426-31. PubMed ID: 19102045
    [Abstract] [Full Text] [Related]

  • 10. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
    Coppola G, Auricchio G, Federico R, Carotenuto M, Pascotto A.
    Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068
    [Abstract] [Full Text] [Related]

  • 11. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K, Wang X, Xi Z, Yan Y.
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [Abstract] [Full Text] [Related]

  • 12. Lamotrigine extended-release as adjunctive therapy with optional conversion to monotherapy in older adults with epilepsy.
    Wechsler RT, Leroy R, Van Cott A, Hammer AE, Vuong A, Huffman R, VanLandingham K, Messenheimer JA.
    Epilepsy Res; 2014 Aug; 108(6):1128-36. PubMed ID: 24888248
    [Abstract] [Full Text] [Related]

  • 13. Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP, Vos AM, Hulsman J, Lambrechts D, Leenen L, Majoie M, Savelkoul M, Schellekens A, Aldenkamp AP.
    Epilepsy Behav; 2008 Feb; 12(2):262-8. PubMed ID: 18093878
    [Abstract] [Full Text] [Related]

  • 14. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS, Kothare SV, Valencia I, Melvin JJ, Legido A.
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [Abstract] [Full Text] [Related]

  • 15. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].
    Yamamoto T, Yamazoe T, Fujimoto A, Kobayashi R, Yokota T, Okanishi T, Uchiyama G, Ohashi T, Tanaka T, Enoki H.
    Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132
    [Abstract] [Full Text] [Related]

  • 16. [Lamotrigine in refractory partial and general epilepsies].
    Mauri-Llerda JA, Tejero C, Espada F, Iñiguez C, Morales F.
    Rev Neurol; 2014 Jan; 32(1):42-5. PubMed ID: 11293097
    [Abstract] [Full Text] [Related]

  • 17. Lamotrigine therapy of epilepsy with Angelman's syndrome.
    Dion MH, Novotny EJ, Carmant L, Cossette P, Nguyen DK.
    Epilepsia; 2007 Mar; 48(3):593-6. PubMed ID: 17326790
    [Abstract] [Full Text] [Related]

  • 18. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
    Baumann RJ, Fakhoury TA, Kustra RP, Vuong A, Hammer AE, Messenheimer JA.
    Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological outcomes in newly diagnosed epilepsy.
    Mohanraj R, Brodie MJ.
    Epilepsy Behav; 2005 May; 6(3):382-7. PubMed ID: 15820347
    [Abstract] [Full Text] [Related]

  • 20. A survey comparing lamotrigine and vigabatrin in everyday clinical practice.
    Schapel G, Chadwick D.
    Seizure; 1996 Dec; 5(4):267-70. PubMed ID: 8952011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.